Overview

A Relative Bioavailability Study of Cetirizine HCl 10 mg Tablets Under Fasting Conditions

Status:
Completed
Trial end date:
2006-09-01
Target enrollment:
Participant gender:
Summary
To determine the pharmacokinetics and bioequivalence of cetirizine hydrochloride formulations after administration of single doses to normal healthy subjects under fasted conditions. These data were to be evaluated statistically to determine if the products meet bioequivalence criteria.
Phase:
Phase 1
Details
Lead Sponsor:
Actavis Inc.
Treatments:
Cetirizine